4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-114786
Chief Executive Officer sold 4,293 shares at $46.28 ($198,680)
- Chief Executive Officer acquired 8,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…